Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

631 public trials 195 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Completed

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

NCT01363232

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +23 more
Locations
  • Massachusetts General Hospital Mass General 2 Boston, Massachusetts, United States
  • Karmanos Cancer Institute Study Coordinator Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center MSKCC (2) New York, United States
  • Cancer Centers of the Carolinas CCC Faris Greenville, South Carolina, United States
View Trial Details
Completed

MEK162 and RAF265 in Adult Patients With Advanced Solid Tumors Harboring RAS or BRAFV600E Mutations

NCT01352273

Conditions
Advanced Solid Tumors
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • Oregon Health & Science University OHSU 3 Portland, Oregon, United States
  • University of Utah / Huntsman Cancer Institute Huntman 2 Salt Lake City, Utah, United States
  • Pfizer Investigative Site Edmonton, Alberta, Canada
View Trial Details
Completed

A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors

NCT01999972

Conditions
Advanced Solid Tumors, Carcinoma, Neoplasms, +2 more
Locations
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Investigational Drug Services IUHSCC Indianapolis, Indiana, United States
  • IU Health University Hospital Indianapolis, Indiana, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 17 locations
View Trial Details
Completed

A Study of ARRY-438162 (MEK162) in Patients With Advanced Cancer

NCT00959127

Conditions
Advanced Solid Tumors, Advanced or Metastatic Biliary Cancer, Biliary Tract Diseases, +15 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber/Harvard Cancer Center Boston, Massachusetts, United States
View Trial Details
Completed

Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia

NCT02316197

Conditions
Advanced Solid Tumors, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • UZ Leuven Leuven, Belgium
  • Rigshospitalet - Onkologisk KFE Copenhagen, Denmark
  • Herlev Hospital University of Copenhagen Herlev, Denmark
View Trial Details
Completed

Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies

NCT01781429

Conditions
Advanced Solid Tumors
Locations
  • UCLA Med-Hematology & Oncology Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists and Research Group (Sarah Cannon Research Institute) Sarasota, Florida, United States
  • Massachusetts General Hospital (MGH) Boston, Massachusetts, United States
View Trial Details

Related conditions